Adapting the 14-day rule for embryo research to encompass evolving technologies

Q1 Social Sciences

Reproductive Biomedicine and Society Online Pub Date : 2020-06-01 DOI:10.1016/j.rbms.2019.12.002

Kate Williams , Martin H. Johnson

引用次数: 18

Abstract

We consider the scientific evidence that research on in-vitro development of embryos beyond 14 days is necessary. We then examine potential new developments in the use of stem cells to make embryoids or synthetic human entities with embryo-like features, and consider whether they also require legal control. Next, we consider the arguments advanced against extending the 14-day period during which research on human embryos is currently permitted, and find none of them to be convincing. We end by proposing a new objective limit that could serve as a mechanism for regulating the use of embryos for research in vitro.

Abstract Image

查看原文本刊更多论文

调整胚胎研究的14天规则，以涵盖不断发展的技术

我们认为有科学证据表明，有必要研究14天以上胚胎的体外发育。然后，我们研究了利用干细胞制造胚胎样或具有胚胎样特征的合成人类实体的潜在新发展，并考虑它们是否也需要法律控制。接下来，我们考虑反对延长目前允许对人类胚胎进行研究的14天期限的论点，并发现其中没有一个是令人信服的。最后，我们提出了一个新的客观限制，可以作为调节体外研究中胚胎使用的机制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Reproductive Biomedicine and Society Online Social Sciences-Cultural Studies

CiteScore

5.40

自引率

0.00%

发文量

审稿时长

7 weeks

期刊介绍： RBMS is a new journal dedicated to interdisciplinary discussion and debate of the rapidly expanding field of reproductive biomedicine, particularly all of its many societal and cultural implications. It is intended to bring to attention new research in the social sciences, arts and humanities on human reproduction, new reproductive technologies, and related areas such as human embryonic stem cell derivation. Its audience comprises researchers, clinicians, practitioners, policy makers, academics and patients.